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ABSTRACT
MAGNETIC IRON OXIDE NANOPARTICLES: SYNTHESIS,
CHARACTERISTICS, MAGNETIC BEHAVIOR, AND BIOMEDICAL
APPLICATIONS
by
Chengyin Fu

Magnetic iron oxide nanoparticles are attracting increasing attention due to their
interesting properties that can be applied in a great number of applications such as
catalysis and biomedicine. This thesis focuses on the synthesis, characteristics, and
biomedical applications of iron oxide nanoparticles. The two most common iron oxides,
including magnetite and maghemite, are discussed in this thesis.
For most of their applications, the magnetic behavior of iron oxide nanoparticles
in a fluid is very important, especially, the high gradient magnetic separation of the
particles from a nonmagnetic liquid medium, such as blood in the human body. A 2D
model, which represents a slice through the center of a spherical particle in a fluid, is
created in this thesis, and only the magnetic force and the drag force are taken into
consideration. The magnetization of the particle is calculated by using the Langevin
function, and the fluid drag force is calculated by using the Navier–Stokes equation. The
trajectory function for this model is calculated, and the trajectories are drawn for specific
cases.
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CHAPTER 1
INTRODUCTION

Nanoscience is the study of matters whose size is on the nanometer scale. Comparing to
the bulk materials, the materials on nanoscale have many unusual properties such as
electrical, optical, and magnetic properties. Iron oxide nanoparticles are iron oxide
particles with diameters between 1 and 100 nanometers. They have attracted much
attention due to their fine magnetic properties and massive fields of applications in
modern science.
The most common iron oxides in nature and biomedical applications are
magnetite (Fe304) and maghemite (γ-Fe2O3), so they are also the subject of this thesis.
The physical propertied of them are listed in Table 1.1.

Table 1.1 Physical Properties of Iron Oxides [1]
Properties
Density (g/cm3)
Melting point (°C)
Hardness
Type of magnetism
Curie temperature (K)
Ms at 300K (A-m2/kg)
Standard free energy of
formation ΔGf° (kJ/mol)
Crystallographic system
Structural type
Space group

Magnetite (Fe3O4)
5.18
1583-1597
5.5
Ferromagnetic
850
92-100
-1012.6

Maghemite (γ-Fe2O3)
4.87
5
Ferromagnetic
820-986
60-80
-711.1

Cubic
Inverse spinel
Fd3m

Lattice parameter (nm)

a = 0.8396

Cubic or tetrahedral
Defect spinel
P4332 (cubic); P41212
(tetragonal)
a = 0.83474 (cubic);
a = 0.8347, c = 2.501
(tetragonal)
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Magnetite is a black magnetic mineral and also called iron(II,III) oxide or ferrous
ferrite. The molecular formula, Fe3O4, can also be written as FeOFe2O3, which consists
of wüstite (FeO) and hematite (Fe2O3). It has the strongest magnetism of all the natural
minerals existing on the Earth [2]. Maghemite is a brown magnetic mineral, which occurs
in soils. It exhibits strong magnetism, and it is metastable with respect to hematite and
forms a continuous metastable solid solution with magnetite [3].
Magnetite and maghemite have the same crystal structure. The iron and oxygen
ions form a face-centered cubic crystal system, and the oxygen ions are in the cubic
close-packed arrangement (Figure 1.1). Magnetite has an inverse spinal structure, and
Fe3+ ions occupy all the tetrahedral sites and both Fe3+ and Fe2+ ions occupy all the
octahedral sites. Maghemite has a spinal structure. Differing with magnetite, vacancies
exist in the octahedral sites in maghemite, and Fe3+ ions occupy two-third of the sites.
!

!

One unit cell of maghemite contains 32 oxygen ions, 21   !  Fe3+ ions, and 2   ! vacancies.

Figure 1.1 Crystal structure of magnetite and maghemite [1].

CHAPTER 2
BASIC MAGNETIC PROPERTIES OF IRON OXIDE NANOPARTICLES

Iron atom has four unpaired electrons in 3d orbital, so it has a strong magnetic moment.
Fe3+ ions have five unpaired electrons in 3d orbital, and Fe2+ ions have four. When
crystals are formed from iron atoms or Fe3+ and Fe2+ ions, they can be in ferromagnetic,
antiferromagnetic or ferrimagnetic states [4].
In the paramagnetic state, all the magnetic moments are randomly oriented, so the
crystal has a zero net magnetic moment (Figure 2.1). The crystal has a small net magnetic
moment when an external magnetic field is applied, and the magnetic moment is zero
when the field is removed. In a ferromagnetic crystal, all the magnetic moments are
aligned even without an external magnetic field. In a ferrimagnetic crystal, two types of
atoms with different magnetic moments are aligned in an antiparallel fashion, and the
antiparallel moments have different magnitudes. The crystal is antiferromagnetic if the
antiparallel moments have the same magnitudes. Both magnetite and maghemite are
ferrimagnetic.

3

4

Ferromagnetic crystals
Paramagnetic state

Antiferromagnetic crystals

Ferrimagnetic crystals

Figure 2.1 The magnetic spin alignments in different types of crystals.

The magnetization, M, represents the net magnetic moment per unit volume that
is aligned parallel to the external field. The magnitude of M is generally less than the
value when all the magnetic moments are perfectly aligned because different magnetic
domains exit in crystal (Figure 2.2). In each domain, the magnetic moments are perfectly
aligned. However, the moments of all domains are usually not aligned, so the
magnetization decreases.
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Figure 2.2 Magnetic domains in a crystal.

When an external magnetic field, H, is applied to a crystal, the crystal has a
magnetization, M (Figure 2.3). M increases with the increase of H until it reaches its
maximum value called saturation magnetization, Ms. When the field is removed, there is
still a nonzero magnetization called remnant magnetization, Mr. To bring the
magnetization back to zero, a coercivity field, Hc, must be applied in an antiparallel
fashion. The diagram of this relation is called a hysteresis loop.
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Figure 2.3 The Hysteresis loop.

When the size of the crystal decreases, the number of domains decreases as well.
The crystal becomes a single domain when the size is blow some critical value. A single
domain magnetic crystal has no hysteresis loop; it is superparamagnetic, which means it
demagnetizes completely (M=0) when the field is removed. Iron oxide nanoparticles
smaller than about 20 nm often display superparamagnetic behavior at room temperature
[1].
The degree of alignment of magnetic moments is a function of temperature. The
alignment is more disordered when the temperature increases, and beyond a critical
temperature, the magnetization of the crystal becomes zero. For both magnetite and
maghemite, the critical temperature is called Curie temperature, TC. Superparamagnetic
particles are different from this normal behavior; it occurs when the temperature is below
a blocking temperature TB.
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Magnetite has a Curie temperature of 850 K [5]. At room temperature, magnetic
particles that are smaller than 6 nm are superparamagnetic [6]. Their magnetic properties
strongly depend on their synthesis method [7,8] and crystal morphology [9,10].
Maghemite has a phase transformation temperature of 400 °C above which it
changes to hematite. Therefore, the Curie temperature of it is difficult to measure.
However, the temperature is believed to be between 820 K and 986 K [1]. At room
temperature, maghemite particles that are smaller than 10 nm are superparamagnetic [11].
Due to the very small size of the particles, the surface atoms have a very large
percentage of all the atoms. Therefore, the surface effects are very important for
nanoparticles. For the same material, the magnetization of small particles can be smaller
than that of bulk materials. This reduction has been associated with different mechanisms,
such as the existence of a magnetically dead layer on the surface of the particles, the
existence of canted spins, or the existence of a spin-glass-like behavior of the surface
spins [12]. Surface modifications are also very influential to the magnetic properties of
the particles [13,14].

CHAPTER 3
SYNTHESIS OF PARTICLES

The preparation method has a very large effect on the size, shape, size distribution, and
surface chemistry of the magnetic nanoparticles and also on their applications [15]. To
synthesize the magnetic nanoparticles with customized size and shape has been always a
challenge. Many synthesis methods have been developed to attain the desired particles;
Figure 3.1 shows the three most important published routes of the preparation methods.
Chemical synthesis has been the most common route, and almost 90% of the published
work (up to date) is on this subject. In addition, the most common method of synthesis is
the coprecipitation technique of iron salts.

8
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Figure 3.1 A comparison of published work on the synthesis of magnetic nanoparticles
by three different routes [16].

3.1 Coprecipitation
The coprecipitation method is the most promising due to its simplicity and productivity
[17]. It is widely used in biomedical applications because of ease of implementation and
need for less hazardous materials and procedures [18]. In this method, iron oxide
particles are produced by an ageing stoichiometric mixture of ferrous and ferric salts in
aqueous media [19]. The size, shape, and composition of the particles depend on the salts
used, the Fe3+ and Fe2+ ratio, the pH of the solution, the temperature, and the ionic
strength of the media [20].
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The chemical reaction of Fe3O4 formation can be written as:
Fe2+ + 2OH- à Fe(OH)2
Fe3+ + 3OH- à Fe(OH)3
Fe(OH)2 + 2 Fe(OH)3 à Fe3O4 + 4H2O
According to the thermodynamics of this reaction, a complete precipitation of Fe3O4
should be expected between pH 9 and 14, while maintaining a molar ratio of Fe3+:Fe2+ is
2:1 under a non-oxidizing oxygen-free environment [21]. Fe3O4 is not very stable, and it
can be oxidized into γ-Fe2O3 in the presence of oxygen. The reaction can be written as:
Fe3O4 + 0.25O2 + 4.5H2O à 3Fe(OH)3
2Fe(OH)3 à γ-Fe2O3 + 3H2O
To prevent this oxidation in air, an oxygen-free environment is very important. Nitrogen
is used to produce such environment by passing through the solution. The nitrogen
through the solution not only can prevent the oxidation but also reduces the particles size
[22, 23].
There are two steps in the coprecipitation process. Small nuclei are first formed in
the medium when the concentration of the species reaches critical supersaturation, and it
is followed by the growth of the crystal. In the later step, the solutes diffuse to the surface
of the crystal, and the process is controlled by the mass transport. The two steps need to
be separated for producing nanoparticles. For example, the nucleation should not occur
during the crystal growth step [24].
The nucleation and the crystal growth steps are illustrated in the LaMer diagram
(Figure 3.2). In the supersaturated solution, if the nuclei are formed at the same time, the
particles can have a very small size distribution after crystal growth. Therefore, the
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nucleation process usually needs to be accomplished in a very short period of time for
small size distribution of the particles. In addition, the number of particles is determined
by the end of the nucleation process and not changing during the crystals growth.

Figure 3.2 The LaMer Diagram [24].
Adding chelating organic anions (carboxylate or α-hydroxy carboxylate ions, such
as gluconic, citric, or oleic acid) or polymer surface complexing agents (dextran,
polyvinyl alcohol, or starch) during the formation of magnetite nanoparticles can help to
control their size. The addition of organic ions can inhibit either nucleation or crystal
growth according to the ratio between organic ions and iron salts, which means they can
either lead to larger or smaller particles.
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The Sugimoto’s method was a very well established synthesis method, which was
reported in 1980 [25]. In this method, ferrous salt is used in the presence of KNO3 and
KOH.
The most common synthesis method is the Massart’s method, which was reported
in 1981. In the method, FeCl3 and FeCl2 are used in alkali to produce the nanoparticles
[26]. For magnetite synthesis, Sugimoto’s method produces larger particles (30 to 200
nm), and Massart’s method produces smaller particles (<20 nm) (Figure 3.3) [27].
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Figure 3.3 TEM micrographs of magnetite nanoparticles: A. Prepared by Sugimoto’s
method reaction in the presence of excess [OH−]; B. Prepared by Sugimoto’s method
reaction without stirring and without excess of [OH−] or [Fe2+]; C. Prepared by Massart’s
method reaction in the presence of NH4OH; D. Prepared by Massart’s method reaction in
the presence of dispersing agent TMAOH and without NH4OH [27].

In the original Massart’s method, the spherical magnetite particles have a
diameter of 8 nm. The influence of the base (NaOH, ammonia, and CH3NH2), the pH, the
cations added (Na+, Li+, K+, NH4+, N(CH3)4, and CH3NH3+), and Fe3+ and Fe2+ ratio on
the productivity and size of the nanoparticles were studied in the Massart’s report. By
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adjusting all the parameters, the particles with size ranging from 4.2 to 16.6 nm can be
produced [19]. In other reports, the influence of pH and ionic strength were studied, and
particles with size ranging from 2 to 15 nm were produced. In addition, the two
parameters affect the surface composition of the nanoparticles, which means that they
also influence the electronic surface charge of the particles. The shape of the particles is
related to the electronic surface density of the nanoparticles [28,29]. The medium can be
either aqueous media or nonpolar liquids (oil or organic solvents) [30]. In another process
reported by Massart [31], γ-Fe2O3 were produced by a rapid synthesis method, and the
method allowed various coatings, such as α-hydroxyacids, amino acids, hydroxamate,
phosphoryl choline, or dimercaptosuccinic acid.
The influence of Fe2+ and Fe3+ ratio (x) on the particles size, shape, composition,
and magnetic properties has been studied [32]. When the ratio is too small, FeO(OH)
forms in the solution. When x=0.3, there are two phases coexisting. One has a Fe2+ and
Fe3+ ratio of 0.07 and produces 4 nm particles; the other has a ratio of 0.33 and produces
larger particles. When x=0.35, only one phase exists. When x=0.5, the particles are
homogeneous in size and chemical composition.
The iron concentration is also an important factor of synthesis. The optimized
concentration is between 39 and 78 millimolar.
The pH and ionic strength has a large influence on the size of the particles. Due to
their effect on the electrostatic surface charge, the particle size and size distribution width
decreases when pH and ionic strength are increased [24].
In Qiu’s report, the influence of ionic strength on the nanoparticles was carefully
studied [33]. The ionic strength is changed by adding 1 M NaCl solution. The magnetite
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particles with size 1.5 nm are attained in the report, and they are smaller than the particles
formed when there is no added NaCl. In addition, in the solution with higher ionic
strength, the formed particles also have lower saturation magnetization (63 emu/g) than
that of normal particles (71 emu/g).
The mixing rate also influence the size of the particles. When the mixing rate
increases, the size of the particles tends to decrease. For example, a decrease of the size is
observed when the base is added to the reactives comparing to the opposite process [19].
The influence of temperature has also been studied by some reports. For the
formation of magnetite nanoparticles, the number of particles decreases when the
temperature increases [34].

3.2 Hydrothermal Methods
Hydrothermal synthesis methods have been reported to produce magnetite nanoparticles.
In these methods, reactions are performed in aqueous media in reactors or autoclaves, and
the temperature needs to be higher than 200 °C and the pressure needs to be higher than
2000 psi [35,36].
There are two main routes for the formation of ferrites via hydrothermal
conditions: hydrolysis and oxidation or neutralization of mixed metal hydroxides. These
two reactions are very similar, except that ferrous salts are used in the first method [37].
In the method, the solvent, temperature and time have great effects on the
particles [38]. The size of the particles increases when the time of the reaction increases
and also when the amount of water increases. The formation of the particles also has two
steps: nucleation and crystal growth. At higher temperatures, the nucleation process is
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faster than the crystal growth, so the size of the particles decreases. At longer reaction
time, the crystal growth dominates, so larger particles are formed. Magnetite
nanoparticles with size 27 nm have been produced by hydrothermal method, and bis(2ethylhexyl) sulfosuccinate sodium salt are used as a surfactant [39].

3.3 High-temperature Decomposition of Organic Precursors
The decomposition of iron precursors in the presence of hot organic surfactants is able to
produce iron oxide nanoparticles with good size control, narrow size distribution, and
good crystallinity, and the produced particles are also well dispersed [40]. The iron
precursors include Fe(Cup)3, Fe(CO)5, or Fe(acac)3. For example, the decomposition of
iron carbonyl in the presence of octyl ether and oleic acid at 100 °C can produce iron
oleate. Cooled to room temperature, (CH3)3NO is added and the solution is refluxed [40].
The decomposition of iron pentacarbonyl in the presence of oleic acid and aging at
300 °C can produce magnetite nanoparticles with a very good crystallinity, and the size
of particles is from 4 to 16 nm [40]. In this method, the size and shape of the particles are
determined by the reaction time, temperature, precursors, concentration, ratios of the
reactants, and solvent. The surfactant on the surfaces of the particles is used to stabilize
the colloid solution.
The thermal decomposition of iron carbonyl in the presence of octyl ether and
oleic acid and using consecutive aeration can produce hydrophobic magnetite
nanoparticles with narrow size distribution [41].
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The decomposition of iron acetylacetonate with 1,2-hexadecanediol in the
presence of oleylamine and oleic acid at high temperature has been reported. The
particles that are produced have a size ranging from 4 to 20 nm [42].
The thermal decomposition of iron oleate and iron pentacarbonyl in organic
solvent at different temperatures can produce particles with size ranging from 4 to 11nm
[43].
The iron oxide nanoparticles produced are dispersible in some organic solvents,
but most of them are not dispersible in water. The decomposition of Fe(acac)3 or FeCl3 in
refluxing 2-pyrrolidone can produce water-dispersible particles in acidic or basic media
[44,45]. 2-pyrrolidone has a good coordination capacity with metal ions, so it is not only
a solvent with high boiling temperature but also a stabilizer. In the report, the size of the
particles can be 4, 12, and 60 nm according to different reflux time [44]. In another report
about the decomposition of Fe(acac)3 in high boiling organic solvent, the particles with
size of 4, 6, 9, and 12 nm are produced. These particles have a very narrow size
distribution, and they are coated by 2,3-dimercaptosuccinic acid and are dispersible in
water [46].
Recently, the decomposition of Fe3(CO)12 in the presence of oleic acid and
diethylene glycol diethyl ether has been reported. The produced particles are then
annealed at 300, 700, and 900 °C. The annealing temperature helps to control the size,
size distribution, composition, and magnetic properties of the particles [47].
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3.4 Sol-Gel Methods
The sol-gel process is a wet-chemical technique, and it is based on the hydrolysis and
condensation of precursors in a colloidal solution (sol). A metal oxide network (gel) is
formed by solvent removal or chemical reaction. A colloidal gel is produced by basic
catalysis; a polymeric form of the gel is produced by acid catalysis [48].
The rates of hydrolysis and condensation are very important parameters in the
method, and it largely influence the properties of particles produced. The lower and more
controlled hydrolysis rate can produce smaller particles. The size of the particles is also
related to the solvent, concentration, pH, and temperature [49].
After a heat treatment of the gel at 400 °C, γ-Fe2O3 particles with size ranging
from 6 to 15 nm are formed [50]. The method allows the predetermination of the
structure of the particles according to the experimental conditions. Using this method, γFe2O3 nanoparticles can be coated in an inert, inorganic, transparent, and temperatureresistant silica matrix [51,52].
In most methods, to produce iron oxide-silica composites, iron oxide precursors
need to be mixed with silica precursors in a solvent to form a sol [53-55]. The iron oxidesilica aerogel composites that are produced by sol-gel method are more reactive than
conventional iron oxide [48]. The increase in reactivity is because of the large surface
area of the particles supported on the silica aerogel [56].
FexOy-SiO2 nanoparticles have been produced using alkoxide and aqueous routes
[57]. The influence of some different silica precursors on the properties of the final
particles has been studied.
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3.5 Microemulsions
A microemulsion is defined as a thermodynamically stable isotropic dispersion of two
immiscible liquids, since the nanosized domain of either or both liquids has been
stabilized by an interfacial film of surface-active molecules [58]. In water-in-oil
microemulsion systems, the microdroplets of the aqueous phase surrounded by surfactant
molecules are dispersed in a continuous oil phase [59]. The surfactant molecules limit the
nucleation, growth, and agglomeration of the particles [60]. When an iron salt solution is
added to the microemulsion, the iron salt will be contained in the aqueous microdroplets.
This microdroplets will continuously collide, coalesce, and break again [61]. Therefore, if
two reactants are added in microemulsion, the precipitate of the resultant will be formed.
The growth of the particles is a progress of interdroplet exchange and nuclei aggregation
[62, 63]. The precipitate can be extract from the surfactants.
Using aqueous core with aerosol-OT/n-hexane reverse micelles in microemulsion
has produced the iron oxide nanoparticles with a very small size distribution (Figure 3.4)
[64]. The aqueous core is used to dissolve reactants. In the report, the solution of Fe3+ and
Fe2+ salts with ratio 2:1 was dissolved in the aqueous core. A deoxygenated solution of
sodium hydroxide is used to achieve precipitation. The magnetite nanoparticles with
smaller size and narrower size distribution have been produced in the presence of
nitrogen gas at low temperature (Figure 3.5) [65]. Due to the very small size (nanometer
range) of the aqueous core, the particles formed usually have a size less than 15 nm and a
very narrow size distribution (Figure 3.6). The biggest advantage of the microemulsion
method is that it can control the size of the particles by controlling the size of the aqueous
core [66].
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Figure 3.4 The structure of an aqueous core with aerosol-OT/n-hexane reverse micelles
[64].

Figure 3.5 The microemulsion method producing highly monodispersed iron oxide
nanoparticles [65].
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Figure 3.6 Transmission electron microscopy pictures of magnetic particles prepared in
(a) bulk solutions and (b) in w/o microemulsions [21].

3.6 Polyol Methods
The iron oxide nanoparticles can be produced by the reduction of dissolved iron slats and
direct precipitation in the presence of polyol [67, 68].
The polyols, such as polyethyleneglycol, have some good properties, such as the
high dielectric constant, the ability to dissolve inorganic compounds, and the high boiling
temperatures. They offer a wide range of the operating temperature for the production of
inorganic compounds [69]. They are used not only as the agents of reduction but also as
the stabilizers, and they can control the growth of particles and prevent aggregation.
In polyol method, precursor is suspended in a liquid polyol. The suspension is
stirred and heated to a given temperature that reaches the boiling point of polyol. The
precursor becomes soluble in the diol during the process, and then it reduced to form
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metal nuclei that will form metal particles. The particles with desired size and shape can
be produced by controlling the kinetic of the process.
The yield of iron oxide nanoparticles produced by this method depends on the
type of polyols, ferrous salts, concentration, and temperature. The size and yield of the
particles are related to the reduction potential of the polyols [70].
In one report, the non-aggregated magnetite nanoparticles have been produced by
a modified polyol method [71]. Four different polyols, including ethylene glycol,
diethyleneglycol, triethylene glycol, and tetraethylene glycol, are used to react with
Fe(acac)3 at an elevated temperature. The non-aggregated magnetite nanoparticles with
narrow size distribution and uniformed shape are only produced when using triethylene
glycol.

3.7 Electrochemical Methods
The γ-Fe2O3 nanoparticles with size ranging from 3 to 8 nm have been produced by
electrochemical method [72]. In the method, the particles are produced from an iron
electrode in an aqueous solution of dimethylformamide and cationic surfactant. The size
of the particles is controlled by the current density.
Electrochemical deposition can be used to produce Fe2O3 and Fe3O4 particles
under oxidizing conditions [73].

3.8 Aerosol/Vapor Method
Aerosol methods, including spray and laser pyrolysis, are continuous chemical processes,
and they are allowing for high rate production.
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Spray pyrolysis is a process that a solution of ferric salts and a reducing agent in
organic solvents is sprayed into a series of reactors, where the solvent evaporates and the
solute condenses [74]. The size of the original droplets controls the size of the produced
particles. Using different iron precursors in alcoholic solution can produce maghemite
particles with size ranging from 5 to 60 nm and with different shapes [75].
Laser pyrolysis is a good method to reduce the reaction volume. In the method,
laser is used to heat a flowing gaseous mixture of iron precursor, and non-aggregated
particles with small size and narrow size distribution can be produced. By controlling the
experimental conditions, maghemite particles produced can have a size ranging from 2 to
7 nm and a very narrow size distribution [76, 77]. For example, maghemite nanoparticles
with a size of 5nm have been produced by continuous laser pyrolysis of Fe(CO)5 vapors
[78].

3.9 Sonolysis
The decomposition of organometallic precursors by sonolysis can also produce iron oxide
nanoparticles. Polymers, organic capping agents, or structural hosts can help to limit the
particle growth [79,80]. The rapid collapse of sonically generated cavities generates very
high temperature hot spot, which allows the conversion of ferrous salts into magnetic
nanoparticles. For example, a hydrosol of amorphous magnetite nanoparticles can be
produced by the sonolysis a of Fe(CO)5 aqueous solution in the presence of sodium
dodecyl sulfate [81].
Well-defined supermagnetic iron oxide nanoparticles have been produced by
sonolysis [82]. In the report, the produced particles are coated with oleic acid, a
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surfactant, and they can be dispersed in chitosan solution. The coated particles have a size
of 65 nm, and they are very stable.
For applications, the particle size, size distribution, particles shape, and magnetic
properties are the very important characteristics, and different characteristics of the
particles can be obtained by different fabrication methods (Table 3.1).

Table 3.1 Comparison of Different Characteristics of the Iron Oxide Nanoparticles
Produced by Different Fabrication Methods
Characteristics Bulk solution
of the particles method
Size
2-50 nm
Size distribution
Broad
Spherical (large
Morphology

Aerosol/vapor
method
5-60 nm
Broad

Sol-gel
method
6-200 nm
Broad

Microemulsion
method
4-15 nm
Narrow

Spherical

Magnetization

10-50 emu/g
with desired
magnetic
property
High production
rate

Spherical with
high porosity
10-40 emu/g
with
paramagnetic
behavior
Particles of
desired shape
and size can be
synthesized,
useful making
hybrid
nanoparticles
Product usually
contains solgel matrix
components at
their surfaces

Cubic or spherical
(no aggregation)
>30 emu/g with
superparamagnetic
behavior

aggregates)
20-50 emu/g with
superparamagnetic
behavior

Advantages

Large quantities
can be synthesized

Disadvantages

Uncontrolled
oxidation of
maghemite,
diamagnetic
contribution

Large
aggregatates are
formed

Uniform
properties and size
of the
nanoparticles can
be modulated
Surfactants are
difficult to
remove, only a
small quantities of
iron oxide can be
synthesized

CHAPTER 4
CHARACTERISTICS OF PARTICLES

4.1 Stability of Colloids
Iron oxide nanoparticles are prepared and stored in colloidal form, so the stability of the
particles is very important. The stability of the particles is determined by three forces:
hydrophobic-hydrophobic forces, magnetic forces, and van der Waals forces. The
nanoparticles tend to aggregate due to the hydrophobic interactions, and micron clusters
are formed from the aggregation. The micron clusters continue to aggregate due to the
magnetic dipole-dipole interactions, and they are magnetized by neighboring clusters. In
an external magnetic field, the clusters are further magnetized, and their aggregation
increases [83]. The nanoparticles also aggregate in suspension due to van der Waals
forces to minimize the total surface energy. The clusters have low surface areas, have
large volumes, and show ferromagnetic behavior [83]. Therefore, the aggregation by
these forces limits the applications of iron oxide nanoparticles.
Coatings (or stabilizer) are required to stabilize the iron oxide nanoparticles.
Stabilizers, including surfactants and polymers, are usually added during the preparation
process to prevent aggregation of the particles. For biomedical applications, the ideal
coating materials also should be biocompatible and biodegradable. The polymers
generally adhere to the surfaces in a substrate-specific manner [84]. Coatings also can
protect the particles from further oxidization.
The electrostatic and steric repulsion are the two reasons of the stabilization [85].
The electrostatic force depends on the pH and ionic strength of the solution. The steric
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repulsion is hard to predict, and, for polymer coatings, it depends on the molecular
weight and density of the polymer.
The coating materials for the nanoparticles should be carefully chosen. The
coating materials can be both inorganic and polymeric materials [86, 87]. The materials
that have been used as coatings and their applications are listed in Table 4.1 [16].
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Table 4.1 Coating Materials of Iron Oxide Nanoparticles and Their Applications [16]
Materials used
Amorphous silica

Size and size
distribution
20–200 nm, broad

Applications

Advantages

Isolation of
biomolecules, e.g.
genomic and plasmid
DNA, extraction of
nucleic acids from soil,
drug delivery, extraction
of phenolic compounds
from environmental
water
Controlled drug
delivery, removal of
mercury from industrial
effluent, support for
enzyme immobilization
for bio-catalysis,
fluorescence, isolation
of genomic and plasmid
DNA
In vivo NMR imaging,
in vivo contrasting

Does not require any
organic solvents and
eliminates the need for
the repeated
centrifugation, vacuum
filtration or column
separation

Mesoporous silica

10–300 nm, broad

Polyethylene glycol
(PEG)

10–50 nm, narrow

Polyvinyl alcohol (PVA)

10–50 nm, narrow

In vivo imaging and
drug delivery

Polyvinyl pyrrolidine
(PVP)

10–20 nm, narrow

Contrasting and drug
delivery

Polyacrylic acid

∼250 nm, narrow

Target thrombolysis
with recombinant tissue
plasminogen activator

Polystyrene

10–20 nm, narrow

Polymethyl methacrylate

10–50 nm, narrow

Cellular imaging and
DNA hybridization
DNA separation and
amplification

Polydipyrrole/dicarbazole

20–100 nm, broad

DNA hybridization

Uniform pore size, large
surface area, and high
accessible pore volume

Improves the
biocompatibility, blood
circulation time and
internalization
efficiency of the NPs,
easy to functionalize
Prevents coagulation of
particles, giving rise to
monodisperse particles
Enhances the blood
circulation time and
stabilizes the colloidal
solution
Increases the stability
and biocompatibility of
the particles and also
helps in bioadhesion
Stable and uniform size
particles in suspension
Novel, simple and laborsaving; can be applied in
automation system(s) to
achieve high throughput
detection of single
nucleotide
polymorphisms
Molecular diversity for
engineering functional
polyDPyr-/polyDCbzshell outer layers of
magnetic
nanocomposites
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Ethyl cellulose

20–50 nm, broad

Extraction of
pharmaceutical
chemicals

Enhanced the drug
absorption into the
surrounding tissues for a
prolonged period of time
A natural cationic linear
polymer that is widely
used as non-viral gene
delivery system,
biocompatible,
hydrophilic, used in
agriculture, food,
medicine,
biotechnology, textiles,
polymers, and water
treatment
Enhances the blood
circulation time,
stabilizes the colloidal
solution

Chitosan

20–100 nm, broad

Tissue engineering,
hyperthermia

Dextran

10–200 nm, narrow

Isolation of E. coli, drug
delivery, imaging

Starch

10–20 nm, narrow

Contrasting and imaging

Natural polymers,
biocompatible

Liposome

50–200 nm, broad

Imaging, drug delivery,
hyperthermia,
contrasting

Long-circulating time

Albumin

100–200 nm, broad

Cell separation

Magnetic tagging and
separation, does not
affect cell viability and
proliferation

Erythrocytes

10–100 nm, broad

MRI imaging, drug
delivery

Avoids the rapid
clearance by the
reticuloendothelial
system (RES) and
permits a long half-life
in blood circulation

Gelatin

50–100 nm

Isolation of genomic
DNA, drug delivery

Hydrophilic,
biocompatible, natural
polymer. Improves the
efficiency of drug
loading and is a rapid,
simple, and a well-suited
method for DNA
extraction
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4.2 Characterization of Particles
The size and shape of iron oxide nanoparticles are also very important parameters
because they are not only related to the magnetic properties but also related to the
applications of the particles.
“Size” is not a clear concept. It can represent several different parameters. For
example, size can represent the crystalline part of the iron core, the whole iron core
including both the crystalline and amorphous part, the core, the whole particle including
both the core and the coating, or even some value without a geometrical meaning. The
particles also have a range of their size, so the size can represent the number, volume, or
intensity-weighted mean size.
TEM can be used to characterize the size and shape of the particles [88]. By using
TEM, the size of the particle core can be determined. It also provides the details of the
size distribution and the shape of the particles (Figure 3.6). High-resolution TEM is also
used to characterize the particles. It shows the arrangement of the atoms, so it can be used
to study defects and surface atomic arrangement of the particles [89].
XRD can be used to determine the crystalline structure of the particles. In a XRD
diffraction pattern, the intensity of the iron oxide peak can be used to determine the
proportion of iron oxide formed in a mixture by comparing the experimental peak and
reference peak intensities [90]. The size of the crystal can be determined from the line
broadening in the XRD pattern using the Scherrer formula [91].
Small-Angle Neutron Scattering (SANS) can be used to characterize the size, size
distribution, shape, and structure of the particles [92]. Dynamic light scattering (DLS) is
used to determine the particle size [93].
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The surface properties of coated iron oxide nanoparticles can be investigated by
atomic force microscopy (AFM or CFM), secondary ion mass spectrometry (SIMS),
infrared spectroscopy (IR), Fourier transform infrared spectroscopy (FTIR), X-ray
photoelectron spectroscopy (XPS), thermogravimetric analysis (TGA), differential
scanning calorimetry (DSC), thermal desorption spectroscopy (TDS), conductimetry,
potentiometry, or solid-state nuclear magnetic resonance (SSNMR) [94]. These
techniques are used to not only determine the nature and strength of the bonding between
the iron oxide surface and the coating but also understand the effect of the coating on the
magnetic properties of the particles [94].

4.3 Magnetic Properties of Colloids
The size of magnetic iron oxide particles needs to be much smaller than 1 µm in order to
form a colloid suspension. Usually, the size is in the range of 4 nm to 18 nm, which is
smaller than the size of a single domain. Therefore, all the magnetic moments in a
particle are perfectly aligned, which means it is fully magnetized.
For a single domain nanoparticle, the magnetization is related to its anisotropy
energy. The magnetic energy of a nanoparticle depends on the direction of its
magnetization vector (Figure 4.1). The direction that has the minimum magnetic energy
is call anisotropy direction or easy axes, and it depends on the crystal structure of the
particle. The magnetic energy increases with the increase of the angle between the
magnetization vector and the easy axis. The amplitude of this curve is called anisotropy
energy.
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Figure 4.1 Changing of the magnetic energy with the angle between the magnetization
vector and the easy axis [95].

Anisotropy energy is proportional to the volume of the particle, and it is given as:

Ea = K aV
where Ea is the anisotropy energy, Ka is a constant called anisotropy constant, and V is
the volume of the particle.
The Néel relaxation time also depends on the anisotropy energy. In Figure 4.1, the
anisotropy energy gets its minimum value when θ = 0 or π, that are the two easy axis.
These two orientations that are antiparallel to each other have the lowest magnetic
energy, so they are the stable states. Therefore, the magnetic moment in a single domain
nanoparticle usually orients in these orientations that are separated by anisotropy energy
barriers. At a finite temperature, there is a finite probability for the magnetization to jump
over the energy barrier and reverse its direction. This process is called Néel relaxation,
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and the mean time required for the jumps between different easy directions is called the
Néel relaxation time, τN, and it is given as:

! N = ! 0 exp(

Ea
)
kT

where Ea is the anisotropy energy, k is the Boltzmann constant, T is the absolute
temperature, and τ0 is a length of time. τ0 is also a function of the anisotropy energy, and
it is given as:
2
% M s (T ) ( . kT %
" (M s (0)V ) + 1
kT (
!0 =
- + $f '
0
1
+
4
Ea# e -, $ f
Ea *)
& M s (0) *) 0/ Ea '&

where V is the volume of the particle, Ms(0) is the specific magnetization of the particle
at 0 K, Ms(T) is the specific magnetization of the particle at absolute temperature T, γe is
the gyromagnetic ratio of the electron, and ηf is a dimensionless constant and is given as:

! f = !" e M s (0)

where η is the damping constant.
According to the equations, τN increases when Ea increases; however, τ0 decreases
when Ea increases. For small anisotropy energy and high temperatures, Ea<<kT, so the
exponential factor is closed to 1. Therefore, the Néel relaxation time mainly depends on
τ0, which decreases as Ea increases. In contrast, for high anisotropy energy, Ea>>kT, so
the Néel relaxation time mainly depends on the exponential factor. In this case, the Néel
relaxation time increases rapidly with an increasing Ea. τ0 is usually in the range between
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10-10 and 10-9 seconds, and the Néel relaxation time can be anywhere from a few
nanoseconds to years or much longer.
For the magnetic nanoparticles in a colloid, the return of the magnetization to
equilibrium depends on not only the Néel relaxation but also the Brownian relaxation.
Brownian relaxation represents the viscous rotation of the particles under a magnetic field
(Figure 4.2). Thus, the global magnetic relaxation rate of the colloid is equal to sum of
the Néel relaxation rate and the Brownian relaxation rate.

1 1
1
=
+
! !N !B
where τ is the global relaxation time and τB is the Brownian relaxation time, which is
given as:

!B =

3V "
kT
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Figure 4.2 Illustration of the Néel relaxation and the Brownian relaxation in a colloid
[96].

According to the equations, the Néel relaxation component dominates when the
size of the particles is small, and the Brownian relaxation component dominates when the
size of the particles is large. When the relaxation time is much shorter than the time used
to measure the magnetization of the nanoparticles, the particles are superparamagnetic.
The blocking temperature is the temperature at which the magnetic relaxation
time is equal to the measuring time. When the temperature is below the blocking
temperature, a hysteresis can be observed. The blocking temperature is given as:
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TB =

Ea
"! %
k ln $ m '
# !0 &

where TB is the blocking temperature and τm is the measuring time. According to the
equation, the blocking temperature increases with increase anisotropy energy.

CHAPTER 5
BIOMEDICAL APPLICATIONS

Small magnetic iron oxide particles have been used in in vitro diagnostics for nearly forty
years [97]. Because of the unique physical, chemical, thermal, and mechanical properties
of iron oxide nanoparticles, they have been used in a great number of biomedical
applications (Figure 5.1).
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Figure 5.1 Recent biomedical applications of magnetic iron oxide nanoparticles.

Magnetite and magnetite nanoparticles have been used in a lot of biomedical
applications because of their biocompatibility and low toxicity in human body [98]. They
are used for the magnetic resonance imaging contrast agents, drug delivery vehicles, and
immunoassays, and also in magnetic hyperthermia. All these applications require that the
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particles are superparamagnetic at room temperature. Aggregation needs to be avoided to
prevent the blockage of blood vessels. In addition, the stability of the particles in water at
neutral pH is very important for the applications, and the colloidal stability of the
magnetic fluid is related to the coating materials and the size of the particles.
In the application of MRI, superparamagnetic iron oxide nanoparticles are used as
contrast agents in human body for molecular and cell imaging to better differentiate
between healthy and diseased tissue. By using the contrast agents, the resolution of the
MRI in vivo imaging can be microscopic [99].
In the application of drug delivery, superparamagnetic iron oxide nanoparticles
are used as carriers of drugs, which means drugs bear on the surface or in the bulk of the
particles. In an applied external magnetic field, the particles are driven to the desired
region in the body, and the medication can be released locally. This method allows the
reduction of the drug wastage and side effects [100].
Magnetic iron oxide nanoparticles are also used for hyperthermia in cancer
therapy. Superparamagnetic nanoparticles can be used to heat tumor cells to 41-45 °C in
an alternating magnetic field. The damage for normal tissue is reversible, but the damage
for the tumor cells is irreversible [11].
Magnetic iron oxide nanoparticles with polymer coatings have been also used in
cell separation, protein purification, and organic and biochemical syntheses. The coatings
are not only used to enhance the stability but also the functionality of the particles.
All the applications listed above have requirements on the size, size distribution,
shape, structure, chemical composition, and coating material of the particles, and these
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factors are all determined by the preparation method. Therefore, different synthesis
processes are used for different applications.
For most of these applications, the magnetic behavior of iron oxide nanoparticles
in fluid is a very important topic, especially, the high gradient magnetic separation of the
particles from a nonmagnetic liquid medium, such as blood in the human body, in an
external magnetic field. Many biomedical applications, such as drug delivery, cell
separation, and protein purification, and industrial applications, such as ore refinement
and water treatment, are based on this model.

CHAPTER 6
MAGNETIC IRON OXIDE NANOPARTICLES IN FLUIDS

6.1 Model
In this thesis, a simple 2D model, which represents a slice through the center of a
spherical particle in a fluid, is considered (Figure 6.1). The fluid flows in a channel, and a
magnetic field is applied perpendicular to the channel walls. The particle is attracted
toward the wall by the magnetic force and will be captured at the inner surface of the
wall. The superparamagnetic nanoparticle in this model consists of a single domain
crystalline core and a coating layer. The coordinate origin sets at the bottom of the
channel.
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Figure 6.1 Schematic diagram of the model.

6.2 The Forces and Trajectory
To separate the particle from the fluid, the magnetic force on the particle must overcome
the opposing forces, including fluid drag, gravitational, and inertial forces. In this case,
since the size of the particle is in nanoscale, only the influence of the magnetic and drag
forces are considered.
By definition, the magnetic force can be written as:

Fm = m ! "B = µ0Vc M c ! "H
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where m is the magnetic moment of the particle, µ0 is the permeability of free space, Vc is
the volume of the core, Mc is the magnetization of the core, and H is the magnetic field.
The magnetization of the core of the superparamagnetic nanoparticle is proportional to
the Langevin function.

M c = Npm L(x)
where N is the number of atoms per unit volume, pm is the magnetic dipole moment per
atom, and L(x) is the Langevin function, which is given as:

L(x) = coth(x) !

1
x

with

x=

µ 0 pm H
kT

where k is the Boltzmann constant and T is the temperature. By definition,

µ0 Npm2
!=
3kT
where χ is the magnetic susceptibility.
From all the equations above, the relation can be derived as:

Mc =

3!
H
!+3

so

Fm =

3µ0Vc !
" #H 2
!+3
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According to the equation above, the magnetic force toward the bottom of the
channel is proportional to the volume of the particle core, the magnetic field gradient, and
the magnetic field at the location of the particle. It can also be written as:

4!µ0 rc3 "
Fm =
# $H 2
"+3
where rc is the radius of the particle core.
The other force in the fluid is the horizontal drag force, which exerts on the
spherical particle, so it can be given by the Navier–Stokes equation:

Fd = 6!"rp vx
where η is the viscosity of the liquid medium, rp is the radius of the whole particle, and vx
is the flow velocity at the center of the particle, which can be given as:

vx =

4vmax
(Dy ! y 2 )
2
D

where vmax is the maximum flow velocity at the center of the channel and D is the
diameter of the channel. y is in the range between 0 and D	
   . Therefore, the horizontal
drag force can be finally written as:

Fd =

24!"rp vmax
D2

(Dy # y 2 )

According to the equation, the drag force is proportional to the radius of the
particle and the velocity of the fluid.
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The trajectory of the particle in the channel from the two forces exerting on the
particle can be calculated. By applying Newton’s law, the small displacement of the
particle in y direction can be given as:

dy = !

Fm
dx
Fd

then

µ0 rc3 D 2 "#H 2
(y ! Dy)dy =
dx
6$rp vmax ( " + 3)
2

If the particle originally at the point (0,h), where h is in the range between 0 and D, the
trajectory function of the particle can be derived by integrate both sides of the equation
above.

µ0 rc3 D 2 #$H 2
"h (y ! Dy)dy = "0 6%rp vmax ( # + 3) dx
y

x

2

then, the trajectory function can be written as:

µ0 rc3 D 2 "#H 2
2y ! 3Dy !
x ! 2h 3 + 3Dh 2 = 0
$rp vmax ( " + 3)
3

2

For this model, the equation above is the final form of the trajectory function,
where h is in the range from 0 to D and y is in the range from 0 to h.
According to the equation, the trajectory of the particle in the fluid is related to
the field gradient, diameter of the channel, size of the particle, and viscosity of the liquid
medium.
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6.3 Results
For most biomedical applications, the channel in the model represents blood
vessel, and the liquid medium represents blood. Table 6.1 shows the values that are used
in this simulation.

Table 6.1 The Values Used in the Simulation
Property

Value

Unit

η

0.002

kg m-1 s-1

µ0 H

1

kg s-2 A-1

dH/dy

1*1010

A m-2

χ

1000

vmax

0.001

m s-1

D

50

µm

rc

50*10-9

m

rp

1*10-6

m

Substituting these values into the trajectory function, then the function becomes:

2y 3 ! 150y 2 ! 1557.8x ! 2h 3 + 150h 2 = 0
where the	
  variables x and y have the unit of µm. Therefore, the trajectory of the particle
in the blood vessel depends on the height, h, which the particle is originally at. Figure 6.2
shows the trajectories of the particle starting at different heights.
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Figure 6.2 The trajectories of the particle starting at height 10, 25, and 50 µm, and the x
and y axes have the unit of µm.

When y=0 or 50, the flow velocity vx=0, so the curves have the biggest slope.
When y=25, vx= vmax, so the curves have the smallest slope. Using higher magnetic
gradient or magnetic field, the particle can be captured in shorter distance and vice versa.

CHAPTER 7
CONCLUSIONS

The modern synthesis methods of the iron oxide nanoparticles allow not only the
production of superparamagnetic particles with very narrow size distribution and the
engineering of the surfaces of the particles with different functions. The applications of
the particles strongly depend on the magnetic properties of the particles, and the magnetic
properties of the particles strongly depend the size of the particles. Therefore, the
synthesis methods of the particles are very important for applications. The biomedical
applications of magnetic nanoparticles can provide better diagnostic procedures and
better treatment modalities, therefore, the better quality of our lives.
The magnetic behavior of iron oxide nanoparticles in fluid is a very important
topic for most of the applications, especially, the separation of the particles from a
nonmagnetic liquid medium. For the model created in the thesis, only the magnetic force
and the drag force are taken into consideration. The magnetization of the particle is
calculated by using the Langevin function. The fluid drag force is calculated by using the
Navier–Stokes equation. The trajectory of the particle in the fluid is related to the field
gradient, diameter of the channel, size of the particle, and viscosity of the liquid medium.
This model can be applied to many applications such as drug delivery, cell separation,
protein purification, ore refinement, and water treatment.
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